Apixaban versus warfarin for anticoagulation after left ventricular assist device implantation: A multicenter real-world analysis

Anticoagulation is standard in patients with left ventricular assist devices (LVADs), but the optimal regimen remains uncertain. While warfarin has historically been utilized, the use of direct oral anticoagulants is increasing. Using the TriNetX Collaborative Research Network, we identified adult H...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Vien T. Truong, MD, Giorgi Chilingarashvili, MD, Avilash Mondal, MD, Timothy Raymond, MD, Si Pham, MD, Thomas O'Brien, MD, Eugene S. Chung, MD, Gregory F. Egnaczyk, MD, PhD
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Elsevier 2026-08-01
Serie:	JHLT Open
Soggetti:	left ventricular assist device HeartMate 3 warfarin direct oral anticoagulants apixaban
Accesso online:	http://www.sciencedirect.com/science/article/pii/S2950133426000881
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!